Silverfin false false 30/11/2024 01/12/2023 30/11/2024 Dr Frances Prenna Jones 03/11/2014 19 August 2025 The principal activity of the Company during the financial year was that of human health activities. 09291708 2024-11-30 09291708 bus:Director1 2024-11-30 09291708 2023-11-30 09291708 core:CurrentFinancialInstruments 2024-11-30 09291708 core:CurrentFinancialInstruments 2023-11-30 09291708 core:Non-currentFinancialInstruments 2024-11-30 09291708 core:Non-currentFinancialInstruments 2023-11-30 09291708 core:ShareCapital 2024-11-30 09291708 core:ShareCapital 2023-11-30 09291708 core:RetainedEarningsAccumulatedLosses 2024-11-30 09291708 core:RetainedEarningsAccumulatedLosses 2023-11-30 09291708 core:LandBuildings 2023-11-30 09291708 core:PlantMachinery 2023-11-30 09291708 core:FurnitureFittings 2023-11-30 09291708 core:OfficeEquipment 2023-11-30 09291708 core:ComputerEquipment 2023-11-30 09291708 core:LandBuildings 2024-11-30 09291708 core:PlantMachinery 2024-11-30 09291708 core:FurnitureFittings 2024-11-30 09291708 core:OfficeEquipment 2024-11-30 09291708 core:ComputerEquipment 2024-11-30 09291708 2023-12-01 2024-11-30 09291708 bus:FilletedAccounts 2023-12-01 2024-11-30 09291708 bus:SmallEntities 2023-12-01 2024-11-30 09291708 bus:AuditExemptWithAccountantsReport 2023-12-01 2024-11-30 09291708 bus:PrivateLimitedCompanyLtd 2023-12-01 2024-11-30 09291708 bus:Director1 2023-12-01 2024-11-30 09291708 core:LandBuildings core:TopRangeValue 2023-12-01 2024-11-30 09291708 core:PlantMachinery core:TopRangeValue 2023-12-01 2024-11-30 09291708 core:FurnitureFittings core:TopRangeValue 2023-12-01 2024-11-30 09291708 core:OfficeEquipment core:TopRangeValue 2023-12-01 2024-11-30 09291708 core:ComputerEquipment core:TopRangeValue 2023-12-01 2024-11-30 09291708 2022-12-01 2023-11-30 09291708 core:LandBuildings 2023-12-01 2024-11-30 09291708 core:PlantMachinery 2023-12-01 2024-11-30 09291708 core:FurnitureFittings 2023-12-01 2024-11-30 09291708 core:OfficeEquipment 2023-12-01 2024-11-30 09291708 core:ComputerEquipment 2023-12-01 2024-11-30 09291708 core:Non-currentFinancialInstruments 2023-12-01 2024-11-30 iso4217:GBP xbrli:pure

Company No: 09291708 (England and Wales)

DR FRANCES PRENNA JONES CLINIC LIMITED

Unaudited Financial Statements
For the financial year ended 30 November 2024
Pages for filing with the registrar

DR FRANCES PRENNA JONES CLINIC LIMITED

Unaudited Financial Statements

For the financial year ended 30 November 2024

Contents

DR FRANCES PRENNA JONES CLINIC LIMITED

STATEMENT OF FINANCIAL POSITION

As at 30 November 2024
DR FRANCES PRENNA JONES CLINIC LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

As at 30 November 2024
Note 2024 2023
£ £
Fixed assets
Tangible assets 3 307,112 9,989
307,112 9,989
Current assets
Stocks 4 5,000 5,000
Debtors 5 78,983 513,580
Cash at bank and in hand 67,725 121,545
151,708 640,125
Creditors: amounts falling due within one year 6 ( 123,450) ( 118,260)
Net current assets 28,258 521,865
Total assets less current liabilities 335,370 531,854
Creditors: amounts falling due after more than one year 7 ( 187,347) ( 47,572)
Net assets 148,023 484,282
Capital and reserves
Called-up share capital 100 100
Profit and loss account 147,923 484,182
Total shareholder's funds 148,023 484,282

For the financial year ending 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of Dr Frances Prenna Jones Clinic Limited (registered number: 09291708) were approved and authorised for issue by the Director. They were signed on its behalf by:

Dr Frances Prenna Jones
Director

19 August 2025

DR FRANCES PRENNA JONES CLINIC LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 November 2024
DR FRANCES PRENNA JONES CLINIC LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 November 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Dr Frances Prenna Jones Clinic Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the company's registered office is 33 Shepherd Street, Mayfair, London, W1J 7HY, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Employee benefits

Defined contribution schemes
The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of Financial Position. The assets of the plan are held separately from the Company in independently administered funds.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date. Tax is recognised in the profit and loss account, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit. Deferred tax liabilities are presented within provisions for liabilities on the balance sheet.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Land and buildings 10 years straight line
Plant and machinery 3 years straight line
Fixtures and fittings 3 years straight line
Office equipment 3 years straight line
Computer equipment 3 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Borrowing costs

Borrowing costs that are directly attributable to acquisition, construction or production of qualifying assets, are capitalised as part of the cost of those assets. Capitalisation begins when both finance costs and expenditures for the asset are being incurred and activities that are necessary to get the asset ready for use are in progress. Capitalisation ceases when substantially all the activities that are necessary to get the asset ready for use are complete.

All other borrowing costs are recognised in profit or loss in the period in which they are incurred.

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each reporting date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost. If there is an unconditional right to defer settlement for at least tweleve months after the reporting date, they are presented as non-current liabilities.

Ordinary share capital

The ordinary share capital of the company is presented as equity.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the company during the year, including the director 3 3

3. Tangible assets

Land and buildings Plant and machinery Fixtures and fittings Office equipment Computer equipment Total
£ £ £ £ £ £
Cost
At 01 December 2023 15,191 0 9,380 117,535 520 142,626
Additions 0 315,730 0 1,968 0 317,698
At 30 November 2024 15,191 315,730 9,380 119,503 520 460,324
Accumulated depreciation
At 01 December 2023 6,074 0 9,048 117,501 14 132,637
Charge for the financial year 1,519 18,418 332 132 174 20,575
At 30 November 2024 7,593 18,418 9,380 117,633 188 153,212
Net book value
At 30 November 2024 7,598 297,312 0 1,870 332 307,112
At 30 November 2023 9,117 0 332 34 506 9,989

4. Stocks

2024 2023
£ £
Stocks 5,000 5,000

5. Debtors

2024 2023
£ £
Amounts owed by group undertakings 64,131 76,706
Amounts owed by director 1,915 157,612
Prepayments 12,937 5,179
Other debtors 0 274,083
78,983 513,580

6. Creditors: amounts falling due within one year

2024 2023
£ £
Bank loans 31,000 29,928
Trade creditors 2,762 24,883
Taxation and social security 16,250 56,736
Other creditors 73,438 6,713
123,450 118,260

7. Creditors: amounts falling due after more than one year

2024 2023
£ £
Bank loans 15,500 47,572
Other creditors 171,847 0
187,347 47,572

There are no amounts included above in respect of which any security has been given by the small entity.

8. Financial commitments

Pensions

The company operates a defined contribution pension scheme for the director and employees. The assets of the scheme are held separately from those of the company in an independently administered fund.

9. Related party transactions

Other related party transactions

The directors loan account is repayable on demand and interest is charged on overdrawn balances exceeding £10,000 at the official HMRC rates.

At 1 December 2023, the balance owed by the director was £157,611. During the year, £435,459 was advanced to the director, and £593,140 was repaid by the director. At 30 November 2024, the balance owed to the director was £70.

As at 30 November 2024, there was a balance of £64,131 owed to a company with common shareholders.